Deciding on Birmingham as site of ADA, Genentech's diabetic eye disease manuscript
April 8th 2024Bryan Wilson, executive director of medical affairs at Genentech, details why Birmingham, Alabama was chosen as the community to study the effects of diabetic eye disease among African Americans in a new manuscript from the ADA and Genentech.